Skip to main content
    C

    Creative Medical Technology Holdings Inc (CELZ)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.52
    -0.01 (-1.51%)

    Market Cap: $4.01M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Creative Medical Technology Holdings Inc (CELZ) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Creative Medical Technology Holdings are PharmaCyte Biotech (PMCB), Mustang Bio (MBIO) and BioRestorative Therapies (BRTX). By market cap, Creative Medical Technology Holdings ranks 7th of the 13 companies on this page; CytoMed Therapeutics Limited Ordinary Shares (GDTC) is the largest at $9.90M.

    Peer Comparison

    CELZ's revenue growth of 0.0% is in line with the peer median. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Creative Medical Technology Holdings (CELZ)$4.01MN/AN/A0.0%N/A0.0%0.00%
    PharmaCyte Biotech Inc (PMCB)$3.77MN/AN/A0.0%N/A0.0%0.00%
    Mustang Bio Inc (MBIO)$3.20MN/AN/A0.0%N/A0.0%0.00%
    BioRestorative Therapies Inc (BRTX)$2.06MN/A70.3x0.0%-289.9%-7.3%0.00%
    CytoMed Therapeutics Limited Ordinary Shares (GDTC)$9.90MN/A16.4x0.0%-72.3%-15.9%0.00%
    SeaStar Medical Holding Corporation (ICU)$4.46MN/A1.7x0.0%N/A82.0%0.00%
    Liminatus Pharma, Inc. Class A Common Stock (LIMN)$4.02MN/AN/A0.0%-247.2%0.0%0.00%
    Dermata Therapeutics Inc (DRMA)$3.06MN/A41.3x0.0%N/A0.0%0.00%
    CNS Pharmaceuticals Inc (CNSP)$4.22MN/AN/A0.0%N/A0.0%0.00%
    Tempest Therapeutics Inc (TPST)$7.64MN/AN/A0.0%-783.6%0.0%0.00%
    Calidi Biotherapeutics Inc. (CLDI)$2.29MN/AN/A0.0%N/A0.0%0.00%
    Can Fite Biopharma Ltd ADR (CANF)$4.30MN/A14.3x0.0%-156.8%0.0%0.00%
    Clearmind Medicine Inc. Common Shares (CMND)$2.30MN/AN/A0.0%-56.8%0.0%0.00%
    Peer median$3.90MN/A16.4x0.0%-202.0%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Creative Medical Technology Holdings, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    PharmaCyte Biotech Inc (PMCB)
    PharmaCyte Biotech, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cell therapies for cancer and diabetes in the United...
    PMCB competitors
    Mustang Bio Inc (MBIO)
    Mustang Bio, Inc., a clinical-stage biopharmaceutical company, is focused on translating medical advances in cell and gene therapies into potential cures...
    MBIO competitors
    BioRestorative Therapies Inc (BRTX)
    BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue...
    BRTX competitors
    CytoMed Therapeutics Limited Ordinary Shares (GDTC)
    CytoMed Therapeutics Limited, a pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human...
    SeaStar Medical Holding Corporation (ICU)
    SeaStar Medical Holding Corporation (ICU) is a forward-looking biotechnology company dedicated to innovating treatment solutions for chronic kidney disease via...
    ICU competitors
    Liminatus Pharma, Inc. Class A Common Stock (LIMN)
    Liminatus Pharma, Inc. is a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is headquartered in LA Palma, California.
    LIMN competitors
    Dermata Therapeutics Inc (DRMA)
    Dermata Therapeutics Inc. is a clinical-stage biotechnology company focused on developing innovative therapies for dermatological conditions...
    DRMA competitors
    CNS Pharmaceuticals Inc (CNSP)
    CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, is dedicated to the development of cancer drug candidates for the treatment of brain and central...
    CNSP competitors
    Tempest Therapeutics Inc (TPST)
    Tempest Therapeutics Inc., a clinical-stage oncology company, is dedicated to the development of small molecules that combine targeted and immune-mediated...
    TPST competitors
    Calidi Biotherapeutics Inc. (CLDI)
    Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, engages in developing immunotherapies for the treatment of cancer.
    CLDI competitors
    Can Fite Biopharma Ltd ADR (CANF)
    Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutics for the treatment of cancer...
    Clearmind Medicine Inc. Common Shares (CMND)
    Clearmind Medicine Inc., a preclinical pharmaceutical company, develops new psychedelic drugs to treat neglected health problems.
    CMND competitors

    Frequently Asked Questions About CELZ

    Who are Creative Medical Technology Holdings' main competitors?

    The companies most similar to Creative Medical Technology Holdings include PharmaCyte Biotech (PMCB), Mustang Bio (MBIO), BioRestorative Therapies (BRTX), CytoMed Therapeutics Limited Ordinary Shares (GDTC) and SeaStar Medical Holding (ICU), listed from the closest match.

    Who is Creative Medical Technology Holdings' biggest competitor?

    CytoMed Therapeutics Limited Ordinary Shares (GDTC) is the largest of the similar companies at $9.90M; PharmaCyte Biotech (PMCB) is the closest match by business profile, size, sector and industry.

    How does CELZ stock compare with its competitors?

    CELZ's net margin is 0.0% against a peer median of 0.0%.

    Which of Creative Medical Technology Holdings' competitors pays a higher dividend?

    Creative Medical Technology Holdings pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Creative Medical Technology Holdings bigger than its competitors?

    No. Creative Medical Technology Holdings is 7th by market cap among the 13 companies on this page; the largest is CytoMed Therapeutics Limited Ordinary Shares (GDTC) at $9.90M.